BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 17681481)

  • 1. C-natriuretic peptide: an important regulator of cartilage.
    Pejchalova K; Krejci P; Wilcox WR
    Mol Genet Metab; 2007 Nov; 92(3):210-5. PubMed ID: 17681481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of fibroblast growth factor and C-natriuretic peptide signaling in regulation of chondrocyte proliferation and extracellular matrix homeostasis.
    Krejci P; Masri B; Fontaine V; Mekikian PB; Weis M; Prats H; Wilcox WR
    J Cell Sci; 2005 Nov; 118(Pt 21):5089-100. PubMed ID: 16234329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexamethasone stimulates expression of C-type Natriuretic Peptide in chondrocytes.
    Agoston H; Baybayan L; Beier F
    BMC Musculoskelet Disord; 2006 Nov; 7():87. PubMed ID: 17116261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclic GMP-dependent protein kinase II plays a critical role in C-type natriuretic peptide-mediated endochondral ossification.
    Miyazawa T; Ogawa Y; Chusho H; Yasoda A; Tamura N; Komatsu Y; Pfeifer A; Hofmann F; Nakao K
    Endocrinology; 2002 Sep; 143(9):3604-10. PubMed ID: 12193576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of C-type natriuretic peptide signalling in maintaining cartilage and bone function.
    Peake NJ; Hobbs AJ; Pingguan-Murphy B; Salter DM; Berenbaum F; Chowdhury TT
    Osteoarthritis Cartilage; 2014 Nov; 22(11):1800-7. PubMed ID: 25086404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effects of C-type natriuretic peptide on linear growth and articular cartilage integrity in a mouse model of inflammatory arthritis.
    Bükülmez H; Khan F; Bartels CF; Murakami S; Ortiz-Lopez A; Sattar A; Haqqi TM; Warman ML
    Arthritis Rheumatol; 2014 Jan; 66(1):78-89. PubMed ID: 24449577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hormones and osteoporosis update. Effects of natriuretic peptides on endochondral bone growth].
    Yasoda A; Nakao K
    Clin Calcium; 2009 Jul; 19(7):1003-8. PubMed ID: 19567998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomechanical signals and the C-type natriuretic peptide counteract catabolic activities induced by IL-1β in chondrocyte/agarose constructs.
    Ramachandran M; Achan P; Salter DM; Bader DL; Chowdhury TT
    Arthritis Res Ther; 2011; 13(5):R145. PubMed ID: 21914170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-type natriuretic peptide regulates cellular condensation and glycosaminoglycan synthesis during chondrogenesis.
    Woods A; Khan S; Beier F
    Endocrinology; 2007 Oct; 148(10):5030-41. PubMed ID: 17640987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway.
    Yasoda A; Komatsu Y; Chusho H; Miyazawa T; Ozasa A; Miura M; Kurihara T; Rogi T; Tanaka S; Suda M; Tamura N; Ogawa Y; Nakao K
    Nat Med; 2004 Jan; 10(1):80-6. PubMed ID: 14702637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-type natriuretic peptide in growth: a new paradigm.
    Olney RC
    Growth Horm IGF Res; 2006 Jul; 16 Suppl A():S6-14. PubMed ID: 16716628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dwarfism and early death in mice lacking C-type natriuretic peptide.
    Chusho H; Tamura N; Ogawa Y; Yasoda A; Suda M; Miyazawa T; Nakamura K; Nakao K; Kurihara T; Komatsu Y; Itoh H; Tanaka K; Saito Y; Katsuki M; Nakao K
    Proc Natl Acad Sci U S A; 2001 Mar; 98(7):4016-21. PubMed ID: 11259675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translational research of C-type natriuretic peptide (CNP) into skeletal dysplasias.
    Yasoda A; Nakao K
    Endocr J; 2010; 57(8):659-66. PubMed ID: 20567091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronically elevated plasma C-type natriuretic peptide level stimulates skeletal growth in transgenic mice.
    Kake T; Kitamura H; Adachi Y; Yoshioka T; Watanabe T; Matsushita H; Fujii T; Kondo E; Tachibe T; Kawase Y; Jishage K; Yasoda A; Mukoyama M; Nakao K
    Am J Physiol Endocrinol Metab; 2009 Dec; 297(6):E1339-48. PubMed ID: 19808910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-type natriuretic peptide plasma levels are elevated in subjects with achondroplasia, hypochondroplasia, and thanatophoric dysplasia.
    Olney RC; Prickett TC; Espiner EA; Mackenzie WG; Duker AL; Ditro C; Zabel B; Hasegawa T; Kitoh H; Aylsworth AS; Bober MB
    J Clin Endocrinol Metab; 2015 Feb; 100(2):E355-9. PubMed ID: 25387261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of natriuretic peptide stimulation on tissue-engineered cartilage.
    Waldman SD; Usmani Y; Tse MY; Pang SC
    Tissue Eng Part A; 2008 Mar; 14(3):441-8. PubMed ID: 18333796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Local CNP/GC-B system in growth plate is responsible for physiological endochondral bone growth.
    Nakao K; Osawa K; Yasoda A; Yamanaka S; Fujii T; Kondo E; Koyama N; Kanamoto N; Miura M; Kuwahara K; Akiyama H; Bessho K; Nakao K
    Sci Rep; 2015 May; 5():10554. PubMed ID: 26014585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CREB activation in hypertrophic chondrocytes is involved in the skeletal overgrowth in epiphyseal chondrodysplasia Miura type caused by activating mutations of natriuretic peptide receptor B.
    Yamamoto K; Kawai M; Yamazaki M; Tachikawa K; Kubota T; Ozono K; Michigami T
    Hum Mol Genet; 2019 Apr; 28(7):1183-1198. PubMed ID: 30544148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Genetic basis for skeletal disease. CNP therapy for achondroplasia].
    Yasoda A; Nakao K
    Clin Calcium; 2010 Aug; 20(8):1212-8. PubMed ID: 20675932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide, C-type natriuretic peptide and cGMP as regulators of endochondral ossification.
    Teixeira CC; Agoston H; Beier F
    Dev Biol; 2008 Jul; 319(2):171-8. PubMed ID: 18514181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.